Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

Televitas 3A

Equity
Your universal e-health ecosystem
Key Investment Information Sheet Terms & Conditions
€37,500
total amount raised in round
  • Eligible for a tax reduction
Invest now
4 calendar day reflection period

Revenue & Business Model


Televitas operates a hybrid model that combines recurring revenue streams with flexible project-based income. This structure supports both financial resilience and scalability as the company targets healthcare institutions, employers, and insurers.


Primary Revenue Streams

  • Platform Licensing

    • Pro version for hospitals and large providers with advanced analytics and AI tools.
    • Light version for care centers and smaller institutions.

  • Communication Hub (Hardware-as-a-Service)

    • Offered via monthly subscription for seamless integration into home and care settings.

  • Data Connectors

    • Enable integration with wearables, apps, and sensors.
    • Delivered through scalable, usage-based subscriptions.


Secondary Revenue Streams

  • Digital Pricing Service : Transaction-based revenue tied to automated billing and reimbursement of remote care.

  • Consulting & Integration Services : Time-and-material based support for platform implementation in healthcare environments.

  • Custom Data Services : Development of predictive AI models and tailored reporting, charged per project or daily rate.


Televitas owns 100% of the intellectual property across software, AI models, and hardware components—ensuring control and long-term value capture.





Business Model Logic


Televitas delivers value across four key segments:

  • Healthcare Providers: Integration with EHR systems and real-time data access improve patient outcomes and operational efficiency.
  • Healthcare Professionals: Centralized dashboards help track patient compliance and personalize care.
  • Employers (HR departments): Health monitoring and predictive analytics reduce absenteeism and burnout risk.
  • Insurers: Access to real-time lifestyle and health metrics enables personalized risk models and early interventions.

Each segment is supported by a pricing strategy that blends:

  • Subscription fees (based on users or usage volume)
  • One-time onboarding/integration fees
  • Add-on pricing for advanced analytics, visualizations, or white-labeled services


Scalability & Growth Potential


  • Cloud-native architecture ensures rapid scaling across care institutions, employers, and national borders.
  • Subscription-based income builds predictable, recurring revenue.
  • Consulting and integration deepen customer retention and fuel long-term platform usage.
  • Strategic partnerships with wearable manufacturers, pharma, and public health institutions create additional monetization layers (e.g. licensing, data agreements).


Commercial Traction


A pilot hybrid care project with residential care centers—focused on type 2 diabetes—has already demonstrated ROI:

  • Monthly savings per patient: ~€83
  • Pilot return: ~€413 net per month (10 patients)
  • Full-scale rollout (2,600 patients):

    • Monthly savings: €216,667
    • Televitas cost: €58,200
    • Net benefit: ~€158,000/month

Reimbursement is supported through NIHII codes, digital consultation policies, and partnerships with care groups and regional authorities.


Business plan 5+


Televitas combines the recurring revenue model of a SaaS platform with the real-world urgency of digital healthcare transformation. Backed by public reimbursement frameworks, growing demand for hybrid care, and a mature IP portfolio, it is positioned to:

  • Deliver strong EBITDA growth starting in year 3.
  • Achieve high-margin, scalable revenue through a subscription-first model.
  • Expand internationally with controlled, modular rollouts across public and private health systems.

With proof points in place and market expansion already underway, Televitas offers investors access to a resilient, tech-enabled health platform aligned with macro trends in aging, digitization, and preventive care.






Looking Ahead


  • Expand platform licensing to more care pathways: geriatric, pediatric, chronic care.
  • Launch prevention programs via Health Arena consortium (Q2 2025).
  • Target international markets (NL, EU, US) via existing partnerships and EU health innovation funding.

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €308,500 is available for the Tax Shelter benefit.

Raise summary

Crowd investments €33,000
Committed by others €4,500
Amount raised €37,500
Minimum round €25,000
Maximum round €450,000
Shares in the company (total round) 13.043%
Pre-money valuation €3,000,000
Post-money valuation min. €3,025,000
Post-money valuation max. €3,450,000